La course au vaccin | On part de loin ! | 3

La course au vaccin | On part de loin ! | 3

Up next

Ben & Jerry's vs Häagen-Dazs | Briser la glace | 6

Nous sommes en l’an 2000 et Ben & Jerry’s a désormais un nouveau propriétaire. Mais le nouvel actionnaire ne semble pas partager les valeurs qui avaient été celles des créateurs de l’entreprise. A tel point que les employés se demandent si la marque pourra survivre à de tels chan ...  Show more

Ben & Jerry's vs Häagen-Dazs | Ice crime | 5

Nous sommes en 1998 et Häagen-Dazs et Ben & Jerry’s découvrent que leur succès fait des envieux. Et pas de petits joueurs : Nestlé et Unilever sont bien décidés à entrer eux aussi sur le marché des glaces premium.Mais alors que ces deux géants de l’agroalimentaire injectent des m ...  Show more

Recommended Episodes

Vaccine Wars | Long Shot | 3
Business Wars

It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials.But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculate the worl ...  Show more

What We Can't Know About a Vaccine
Prognosis: Misconception

The race for a COVID-19 vaccine entered a new phase recently. Four different vaccine candidates, developed by Moderna, Pfizer, BionTech and Johnson & Johnson, entered final-stage trials, with two others close behind. But we won’t know exactly how these four vaccines work for mont ...  Show more

How close are we to a vaccine for Covid-19?
The Inquiry

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ...  Show more

Vaccine Wars | Warp Speed | 4
Business Wars

It’s summer 2020 and with Covid infections surging across America, the Trump administration’s ready to spend billions to get a vaccine fast.For vaccine makers — who face the enormous costs of rapidly upscaling manufacturing and pushing their shots through large-scale human trials ...  Show more